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 PROJECT OVERVIEW 
 
Title:  Randomized Controlled Trial of Routine Screening for Intimate Partner Violence   
 
Protocol Summary:  
 
Although screening for intimate partner violence (IPV) has been widely recommended by 
multiple professional and health care organizations, recent systematic reviews of the 
literature have not found evidence for the effectiveness of screening to improve health 
outcomes for women exposed to IPV.  
 
In this protocol, we propose conducting a randomized controlled trial with three arms to 
establish the impact of screening and referral to services for women disclosing exposure 
to IPV. In the first arm, participants will be screened, and if disclosing IPV, will receive 
information on available resources in the community.  In arms two and three, participants 
will not be screened, but one group will receive information on available resources in the 
community and the other will not. All three groups will be assessed for disability, quality 
of life, and utilization of health care and IPV services at baseline and at a 12 month 
follow-up. Utilization of health care and mortality will be assessed at a three-year and 
two-year follow-up, respectively. 
 
 
Investigators: Joanne Klevens, MD, Ph.D. 
 Principal investigator 
 NCIPC/DVP/Prevention Development and Evaluation Branch 
 dzk8@cdc.gov (e-mail) / (770) 488-1386 (phone) 
 
Laura Sadowski, MD, MPH   
Co-Director, Collaborative Research Unit, Cook County Hospital 
Associate Professor, Department of Internal Medicine, Rush Medical  
College, Chicago 
sadowski@cchil.org / (312) 864-3646 
 
Romina Kee MD, MPH 
Senior Investigator, Collaborative Research Unit and Department of  
Obstetrics and Gynecology, John H. Stroger Hospital, Chicago 
romina@mail.cchil.org / (312) 864-3630 
 
   William Trick, MD 
 Senior Investigator, Collaborative Research Unit and Department of  
 Obstetrics and Gynecology, John H. Stroger Hospital, Chicago 
wtrick@cchil.org / (312) 864-3631 
 
 
Collaborators:  Jim Martindale/Colby Moseley 
    Project Officer 
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     NCIPC/CDC/DVP/ Prevention Development and Evaluation Branch 
    Wei4@cdc.gov / 770-488-3785 
 
    Diana Garcia, MPH 
    Research Evaluation Coordinator, Collaborative Research Unit 
    dgarcia@cchil.org / 312-864-3645 
 
    Francisco Angulo, MBA 
    Director, Information Technology, Collaborative Research Unit 
    fangulo@cchil.org / 312-864-1410 
 
 
Roles: Joanne Klevens conceptualized the study and overall design. Joanne Klevens, 
Laura Sadowski, Romina Kee, and William Trick have collaborated in refining the study 
design and selecting the measures, will conduct the pilot test of the measures and 
procedures, and will continue to collaborate in data analysis and publications. Laura 
Sadowski will coordinate the on-site research team and have overall responsibility for 
study implementation including training of field staff and budget management. Romina 
Kee has primary responsibility for local human subjects’ applications and progress 
reports, will co-lead the training of OB/GYN providers and field staff, and has direct 
supervision of implementation of the field staff and health care providers. Romina Kee 
will serve as the Obstetrics & Gynecology lead for study activities and will assist in 
supervising the implementation of study procedures by OB/GYN providers. Dr. Trick 
will be liaison between the technology development, support team, and principal 
investigators. Diana Garcia will supervise research assistants in recruitment of 
participants and consent and interview procedures, and conduct field observations and 
debriefings to check for study fidelity.  
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 RANDOMIZED CONTROLLED TRIAL OF ROUTINE SCREENING 






In this proposal, intimate partner violence (IPV) refers to the intentional use (or threat of 
use) of physical or sexual violence, or emotional/psychological abuse (including coercive 
tactics) by a current or former spouse or dating partner. 
 
The US Task Force defines screening as a “preventive service in which a special test or 
standardized examination procedure is used to identify patients requiring special 
intervention”.1 Preventive services are carried out on asymptomatic persons, that is, 




IPV is a significant public health problem. Nearly 25 percent of surveyed women in the 
U.S. report being physically and/or sexually assaulted by a current or former partner at 
some time during their life.2 Almost 62% of adult women who are sexually assaulted 
have been so by an intimate partner.3 IPV has a multitude of serious consequences that 
include death, physical injury, increased rates of physical illness, posttraumatic stress, 
increased psychological distress, depression, substance abuse, and suicide.4 Children who 
witness IPV are also at increased risk for many behavioral problems, including 
aggressive behavior.5  
 
Early studies documenting the experience of IPV suggested that abuse perpetrated by 
intimate partners tended to be repetitive and escalate in severity over time.6 This research 
has been the basis for promoting early diagnosis and intervention.  Health care providers 
appear to be well situated to identify IPV. Women come into contact with health care 
services routinely for a number of reasons such as prenatal care, family planning, cancer 
screening, and well baby care. Women experiencing IPV make more visits to primary 
                                                 
1 US Preventive Services Task Force. Guide to Clinical Preventive Services (3rd Edition). Baltimore, MD: 
Williams& Wilkins, forthcoming publication.  
2 Tjaden, P. & Thoennes, N. Full Report of the Prevalence, Incidence, and Consequences of Violence 
Against Women. Findings from the National Violence Against Women Survey. Washington, DC: National 
Institute of Justice, 2000. 
3 Ibid., p. 44. 
4 Panel on Research on Violence Against Women, National Research Council. Understanding Violence 
Against Women. Washington, DC:  National Academy of Science, 1997.  
Campbell JC. Health consequences of intimate partner violence. Lancet 2002;359:1331-
1336. 
5 Fantuzzo, JW & Lindquist, CU. The Effects of Observing Conjugal Violence on Children: A Review and 
Analysis of Research Methodology. Journal of Family Violence 1989; 4: 77-94. 
6 Walker, LE. (1984). The Battered Woman Syndrome. New York: Springer. 
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 care facilities than non-abused women.7 For these reasons, various professional and 
health care organizations have recommended routine screening of women for IPV in 
primary care settings.8,9,10,11,12,13, 14,15,16,17  
 
Current standards for making recommendations on screening for a condition are based on 
the grounds of the burden of disease; the availability and acceptability of accurate 
screening tests; the availability and acceptability of effective treatment; and evidence that 
early treatment (during the asymptomatic period) produces better results than waiting for 
the appearance of symptoms and diagnosis.18,19,20 As previously shown, there is clear 
evidence that IPV is prevalent and generates great medical and societal costs. There is 
also evidence for the availability and acceptability of accurate screening tests.21,22 
However, various systematic reviews of the literature have not found evidence for the 
effectiveness of screening to improve health outcomes for women exposed to IPV.21,22, 
23,24 
                                                 
7 Plitcha, S. The effects of woman abuse on health care utilization and health status: A literature review. 
Women’s Health issues 1992; 2: 154-163. 
8 American Academy of Family Physicians (AAFP) Commission on Special Issues and Clinical Interests. 
Family Violence: an AAFP white paper. Am Fam Physician 1994; 50: 1636-46. 
9 American Academy of Pediatrics committee on Child Abuse and Neglect. The Role of the Pediatrician in 
recognizing and intervening on behalf of abused women. Pediatrics 1998; 101:1091-2 
10 American College of Emergency Physicians: Emergency medicine and domestic violence. Ann Emerg 
Med 1995; 25: 442-3. 
11 American College of Obstetricians and Gynecologists (ACOG) Domestic Violence. ACOG Tech Bull 
209. Washington, DC: ACOG, 1995. 
12 American College of Nurse Midwives. Position statement on violence against women. Washington, DC: 
American College of Nurse Midwives, August, 1997. 
13  American Dental Association. Position statement on family violence. Chicago, IL: American Dental 
Association, December, 1996. 
14 American Nursing Association. Position statement physical violence against women. Washington, DC: 
American Nursing Association, September, 1991. 
15  Council on Scientific Affairs, American Medical Association. Violence against women: relevance for 
medical practitioners. JAMA 1992; 267: 3184-9. 
16  Emergency Nurses Association. Position statement: domestic violence. Park Ridge, IL: Emergency 
Nurses Association, 1994.  
17  Joint Commission on Accreditation of Healthcare Organizations. Accreditation manual for hospitals. 
Vol 1- standards. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations 
1992; 21-2. 
18 US Preventive Services Task Fore. Guide to Clinical Preventive Services (3rd Edition). Baltimore, MD: 
Williams & Wilkins, forthcoming publication. 
19 Canadian Task Force on the Periodic Health Examination. Assessing the clinical effectiveness of 
preventive maneuvers. Journal of Clinical Epidemiology 1990; 43: 891-905.   
20 UK National Screening Committee The criteria for appraising the viability, effectiveness, & 
appropriateness of a screening programme. Available at: http://www.nsc.nhs.uk/pdfs/criteria.pdf  
http://www.nhs.uk/criteria.pdf  Accessed May 18, 2011. 
21 US Preventive Services Task Force. Screening for Family and Intimate Partner Violence: 
Recommendation Statement. Ann Intern Med 2004; 140: 382-386. 
22 Ramsay, J, Richardson, J, Carter, Y, Davidson, LL., Feder, G. Should health professionals screen women 
for domestic violence? Systematic review. BMJ 2002; 325: 314-318. 
23 Wathen, C.N. & MacMillan, H.L. Interventions for Violence Against Women. Scientific Review. JAMA 
2003; 289: 589-600.  
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Whether intervention offered to patients during the asymptomatic phase is utilized by 
victims, and is more efficient and effective in improving health than intervening when 
she seeks care for mental or physical symptoms or an injury needs to be established. 
There is also little information on other potential positive and negative effects of 
screening. Screening may lead to greater awareness among women of the frequency and 
seriousness of IPV, or serve as validation of the problem, and increase knowledge of the 
availability of, referral to, and utilization of IPV services and social support among 
victims. However, screening may also have adverse consequences. Qualitative studies 
have suggested that asking women about IPV may reinforce their feelings of being 
stigmatized and increase anxiety.25 Women also report feeling disappointed in their 
health care providers’ behavior, often finding the provider uninterested, uncaring, or 
uncomfortable.26-27 
 
Current recommendations promote health care provider screening and referral. However, 
even if there were evidence of the benefits of screening for IPV, having health care 
providers screen and refer women would be difficult to implement, given the time 
constraints of the primary health care provider-patient encounter.28  Computerized health 
screening is an attractive alternative in that it is relatively low cost, staff free, and 
flexible; can be programmed to screen opportunely; easy to use; and more easily 
introduced into the patient care flow.29 In addition, computer assisted surveys appear to 
achieve higher disclosure rates than self-administered questionnaires or face-to-face 
encounters for many sensitive health issues30,31,32,33,34, including IPV35- 36, is acceptable to 
                                                                                                                                                 
24 Babcock, IC, Wyer, PC, Gerson, LW. Preventive care in the emergency department, Part II: Clinical 
preventive services—an emergency medicine evidence-based review. Society for Academic Medicine 
Public Health and Education Task Force Preventive Services Work Group. Acad Emerg Med 2000; 7: 
1421-3. 
25 Chang, JC, Decker, M, Morocco, KE, Martin, SL, Petersen, R, Frasier, P. What happens when health 
care providers ask about intimate partner violence? A description of the consequences from the perspective 
of female survivors. JAMWA in press. 
26 Hamberger, LK, Ambuel, B, Marbella, A, Donze, J. Physician interaction with battered women: The 
woman’s perspective. Arch Fam Med 1998; 7: 575-582. 
27 Gerbert, B, Johnston, K, Caspers, N, et al. Experiences of battered women in health care settings: A 
Qualitative Study. Women Health 1996; 24: 1-17. 
28 Gilchrist, VJ, Stange, KC, Flocke, SA, McCord, G, & Bourghet C. A comparison of the National 
Ambulatory Medical Survey (NAMCS) Measurement Approach with Direct Observation of Outpatient 
Visits. Medical Care 2004; 42: 276-280. 
29 McNutt, LA, Waltermauer, E, McCauley, J, Campbell, J, Ford, DE. Rationale for and Development of 
Computerized Intimate Partner Violence Screen for Primary Care. Family Violence Prevention and Health 
Practice 2005; 1-14. 
30 Gerbert, B, Bronstone, A, Pantilat, S, McPhee, S, Allerton, M, Moe, J. When asked, patients tell: 
disclosure of sensitive health-risk behaviors. Medical Care 1999; 37: 104-111. 
31 Des Jarlais, DC, Paone, D, Millikenm, J, Audio-computer interviewing to measure risk behavior for HIV 
among injecting drug users: a quasi-randomised trial. Lancet 1999; 353: 1657-1661. 
32 Gribble, JN, Miller, HG, Cooley, PC, Catania, JS, Pollack, L, Turner, CF. The impact of T-CASI 
interviewing on reported drug use among men who have sex with men. Substance Use and Misuse 2000; 
35: 869-890. 
33 Turner, CF, Ku, L, Rogers, SM, Lindberg, LD, Pleck, JH, Sonenstein, FL. Adolescent sexual behavior, 
drug use and violence: increased reporting with computer survey technology. Science 1998; 280: 867-873. 
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 patients and health care providers, and increases solicitation and recall of health advice.37 
Thus, in this study, we will test the effectiveness of computerized routine screening. 
 
Finally, there is some debate about whether screening is actually needed to provide 
information about available IPV resources.38 There is also evidence that many abused 
women do not disclose IPV to their health care provider when they are screened.39 
Routinely providing all women with information on available IPV resources might 
facilitate access to these services for women who are not ready or willing to disclose to 
their health care provider. The effectiveness of this alternative, which we have named 




The objectives of this study are to establish the cost and effectiveness of routine 
screening for IPV and referral to IPV services of asymptomatic women compared to 
universal education or no intervention on disability, quality of life, utilization of health 
care services and IPV services, and exposure to IPV, and to identify other potential side 
effects (adverse and beneficial) of these interventions.  
 
Intended/potential use of study findings 
 
The findings from this study will guide CDC in formulating its recommendations 
regarding routine screening, as well as guiding other governmental agencies, professional 
and health care organizations, and women’s advocate groups in formulating their policies 







We propose conducting a randomized controlled trial with three arms. In the first arm, 
participants will be screened, and only if disclosing IPV, will receive information on 
available resources in the community. In the other two arms, participants will not be 
screened, but one group will receive information on available IPV resources in the 
                                                                                                                                                 
34 Newman, JC, Des Jarlais, DC, Turner, CF, Gribble, J, Cooley, P, Paone, D. The Differential Effects of 
Face-to-Face and Computer Interview Modes. American Journal of Public Health 2002; 92: 294-297. 
35 Rhodes KV, Lauderdale DS, He T, Howes DS, Levinson W.   "Between me and the computer": 
Increased detection of intimate partner violence using a computer questionnaire.   Ann Emerg Med 2002; 
40: 476-484. 
36 Renker PR & Tonkin P.  Women’s Views of Prenatal Violence Screening: Acceptability and 
Confidentiality Issues.  Obstetrics and Gynecology 2006;107: 348-354. 
37 Rhodes, KV. The Promise and Problems of Using Information Technology to Achieve Routine Screening 
for Intimate Partner Violence. Family Violence Prevention and Health Practice 2005; (3): 1-14. 
38 Runyan, D. (2002) Personal communication. 
39 Renker, PR & Tonkin, P. women’s Views of Prenatal Violence Screening. Obst Gynec 2006; 107: 348-
354. 
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 community and the other will not receive this information. All three groups will be 
assessed with a self-report measure for disability, and quality of life at baseline and at a 
12-month follow-up. Health records will be used to assess for utilization of health care in 
the past year at baseline and at one- and three-year follow-ups. Two-year follow-up of 
mortality data will also be collected. Exposure to IPV and utilization of IPV services or 




This study will be conducted at the following facilities that are within the Cook County 
Bureau of Health Services: the Fantus Health Center, the CORE center, Ambulatory 
Health Care Network, and the Rush- Presbyterian-St. Lukes Medical Center. The Bureau, 
which includes the John Stroger Jr. Hospital of Cook County (formerly Cook County 
Hospital) and its 31 community clinics, including the Cermak medical facility at the 
Cook County Jail and two community hospitals (Oak Forest and Provident), annually 
provides 24,644 hospital admissions, 120,000 emergency department visits and over 
600,000 outpatient visits to people who are uninsured and underinsured. 
 
1) The Fantus Health Center, adjacent to Stroger Hospital, is the flagship clinic of the 
Cook County Bureau of Health Services ambulatory facilities. It provides comprehensive 
general medicine, obstetrical, gynecologic and family planning services through several 
mechanisms. Obstetrical services are provided five days a week through both resident 
and midwifery clinics. Gynecological and family planning services are provided five days 
a week by resident, physician assistant, and attending clinics, in addition to family 
planning services which are also provided separately by nurse practitioners through a 
Title X grant. The family planning grant is run under the auspices of the Department of 
Obstetrics and Gynecology; hence staff from the department provides services in both 
clinics. The average number of visits per day to Obstetrics & Gynecology is 90 while 
Family planning averages 25 visits per day. The General Medical Clinic (GMC) is a large 
adult ambulatory care clinic that provides 30,000 continuity ambulatory care visits a year 
and about 240 visits a day.  The majority of patients are African American (80 %), 
women (65%) and have an average age of 61.5 years. 
 
2) CORE Center: Participants will also be recruited from the Ruth M. Rothstein CORE 
Center, a state of the art clinical facility founded by the Cook County Bureau of Health 
Services. The CORE Center is a one-stop approach to treatment and prevention for 
sexually transmitted diseases that serves as a national model for outpatient services. 
Women at the CORE Center are seen in dedicated clinics that operate 4 half days a week 
and offer supportive services such as child-care and case management. Approximately 
85-100 women are seen weekly for HIV related primary or obstetrics & gynecologic care 
and about 30-40 women are seen weekly in the CORE Center Screening clinic which 
provides walk-in services for sexually transmitted infection (STI) related complaints. 
While routine IPV screening is not currently done, the CORE Center recognizes its 
importance and in conjunction with HCIP is certifying a registered nurse to provide 
intervention services in 2009. We expect to enroll 10-15% of the study participants from 
this clinic to ensure representation of this high-risk population. 
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3) The Ambulatory Health Care Network of Cook County provides primary care services 
at 10 community locations – six in Chicago and 4 in adjacent neighborhoods within Cook 
County.  We will select two sites based on their volume of adult women patients as well 
as their interest in serving as a study site.  To be eligible, the clinics will need to provide 
primary care to over 5,000 adult women annually (80% meet this volume criteria) and 
have reliable internet access to meet the aCASI needs of the study. The IPV study will 
enroll 5-10% of the study sample from 1-2 of the clinics located in Chicago. 
 
4) Rush Medical Center, designed to serve approximately 3 million people, is a nonprofit 
academic medical center comprised of Rush University, a 613 bed hospital in Chicago, 
medical centers in Oak Park, Aurora and Skokie, Illinois and the Rush Health Associates, 
a provider network with 700 physicians on staff at various locations. Sites from the 
Medical Center and Rush Health Associates that provide women’s health care services 
will be participating in the project. The initial Rush clinical site will be Rush Associates 
in Women’s Health at 1645 West Jackson street. In that practice 8 attending physicians 
and multiple resident physicians provide outpatient obstetrical and gynecologic services. 
A secondary potential site is the Women’s Health Consultants practice located in the 
professional building on the Medical Center campus which also has 8 attending 
physicians of various subspecialties providing patient service. We anticipate that 15-25% 
of the study population will be recruited from these locations. 
 
 
Tentative Time Table: month starting after completion of pilot study 
Month Project Activity 
1-3 Revise measures/procedures based on pilot test 
Submit amendments to IRB & modifications to OMB 
4-9 Enroll and interview participants 
10 Extract demographics and health care utilization from Electronic Database 
16-21 One-year follow-up interviews 
22-24 Clean and merge databases; Begin manuscript writing 
24-27 Data analysis 
28-36 Finish preparing manuscripts 
46-48 Develop security authorization documentation and plan for protection of 
identifiable information 
49-50 Submit amendment to IRB 
51-52 Pilot query to assess completeness of ICD-9 codes in electronic medical records 
53-56 Extract 3-year health care utilization from Electronic Medical Records 
57-60 Extract and code 2-year mortality from Vital Statistics 
Downloaded From: http://jama.jamanetwork.com/ by a Stephen B. Thacker CDC Library User  on 12/22/2015
 61-62 Mortality data entry, clean and merge health care utilization data 
63-64 Data analysis 
65-70 Preparation of reports 
 
 
Study population  
 
All women at least 18 years of age seeking services at any of the study sites are eligible 
for inclusion. The following table provides our exclusion criteria and rationale: 
 
Exclusion Criteria Rationale 
 
Non-English or Spanish speaking 
Audio programming and video clips in 
multiple languages is cost-prohibitive 
Women accompanied by a child >3 years 
of age who don’t have adequate provision 
for child care 
Older children may compromise the 
privacy of the kiosk and for security 
reasons, they should be with their caretaker 
 
Visually- or hearing-impaired women 
They will be unable to use either the A-
CASI or the touch-screen monitor 
Women who are accompanied by their 
partner and the two can’t safely be 
separated 
Patient privacy is essential for the safety of 
participants 
Women who do not have access to a 
telephone 
 
Unable to complete study task – 1 year 
CATI follow-up 
Women who will not give contact 
information of at least 2 family members 
or friends  
Unable to meet expected CATI 1-year 
follow-up without additional contact 
options 
Severe Mental impairment Unable to give Informed Consent and 
complete study tasks 
 
 
Sample size and statistical power 
 
The sample size needed to detect a standardized effect size of .4 (considered a moderate 
effect size; Cohen, 1998) in QOL and mental health score means at a significance level of 
.05, power of 80%, factoring in a 30% lost-to-follow-up rate40, is 110 abused women in 
each arm. Based on the average obtained from four prevalence studies, we might expect 
that about 13% of women in primary or ambulatory care clinics report being abused by a 
partner in the past year.41,42,43,44 Thus, the minimum sample size needed in each group is 
                                                 
40 Based on observations from Coker, A, Smith, PH, Flerx, VC, et al. Domestic Violence Services in Rural 
Health Care Clinics ongoing screening and intervention trial. 
41 Bauer H, Rodriguez MA, Perez-Stable EJ. Prevalence and determinants of intimate partner abuse among 
public hospital primary care patients. J Gen Intern Med 2000;15: 811-817. 
42 Richardson J, Coid J, Petruckevitch A, et al. Identifying domestic violence: cross-sectional study in 
primary care. BMJ 2002; 324:271-277. 
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 equal to 847. Mean scores on these continuous variables will be estimated based on the 
pilot study and the sample size will be adjusted accordingly.  
 
Given our setting, and the time needed to successfully enroll each participant, our 
enrollment goal minimum will be 300 interviews completed per week.  To achieve this 
goal we intend to enroll from multiple clinics every day. We anticipate our final sample 
will include 30-45% of participants enrolled from the Fantus OB/GYN clinics, 5-10 % 
from other Fantus Primary care clinics such as the General Medical Clinic (GMC), 10-
15% from CORE, 5-10% from other ambulatory health care network clinics and finally 
15-20% from Rush Medical Center clinics.   
 
Identification of potential study participant:  Nursing staff will distribute an 
informational flyer (please see appendix) with the patient’s registration label to patients 
after weight and blood pressure is assessed. Patients may show their interest in the study 
by depositing their flyer in a bin labeled "Women’s Health and Computer Study” on the 
reception desk. These patients will be contacted by a Research Assistant (RA). Women 
who are not interested will be directed to hand it to provider or other staff who will then 
destroy it. In addition, RAs will approach other potential participants during their wait to 
be seen by the providers to determine their interest and then if appropriate their 
eligibility. Regardless of method of recruitment, all potential participants will undergo 
the enrollment and consent process described below. 
 
Enrollment and consent: Women called by the RA in the waiting room will be screened 
for eligibility (see sample script for eligibility in appendix) and, if eligible, invited to 
participate in this study, including the follow-up telephone interview one year later. The 
RA will offer women a copy of the consent form (please see Appendix) and will also read 
it aloud to her. Those consenting will be asked to go to a computer kiosk with the RA and 
respond to the questionnaire. Women will be compensated with $20 at baseline and a $15 
gift certificate at the one-year follow-up for their time.  
 
 
Variables and Measures 
 
Independent variable 
Screening and referral strategies. Participants will be randomly assigned to one of the 
following three arms after they are determined to be eligible and Informed Consent 
procedures are complete: 
 
Arm 1: Audio-computer-assisted structured interview (A-CASI) baseline survey + 
IPV screen, referral if positive;  
                                                                                                                                                 
43 McCauley J, Kern DE, Kolodner K, et al. The “battering syndrome”: prevalence and clinical 
characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med 1995; 123: 
737-746. 
44 Gin NE, Ruker L, Frayne S, et al. Prevalence of domestic violence among patients in three ambulatory 
care internal medicine clinics. J Gen Intern Med 1991; 6: 317-322. 
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 Arm 2: A-CASI baseline survey, no IPV screen, universal education on IPV 
resources; 
Arm 3: A-CASI baseline survey, no IPV screen, no referral information. 
 
Random assignment of study participant:  The CASI program will randomly assign the 
participant to one of 3 study arms as described in the Study Design above. We will 
implement a simple randomization technique. After obtaining informed consent, the RA 
will lead the participant to the kiosk, and activate the CASI program. After the RA enters 
the study ID number into the CASI program, the computer screen will indicate with a 
message/symbol the assigned arm or study group.  
 
IPV screen. The Partner Violence Screen (PVS) will be used to assess the presence of 
current IPV (past year) and women’s perception of being ‘safe’ from IPV45 for 
participants in arm 1.   This 3 item screening tool has been used in Emergency Room 
settings where it was validated using the much longer IPV research instruments   Index 
of Spouse Abuse (ISA) and the Conflict Tactics Scale (CTS) as criterion.  The sensitivity 
of PVS was .65 (compared to ISA) and .71 (compared to CTS); specificity for the PVS 
was .80 (ISA) and .84 (CTS). The three items of the PVS are: 
1. Have you been hit, kicked, punched or otherwise hurt by someone with the 
past year? 
If yes, Follow-up question – by whom? 
2. Do you feel safe in your current relationship? 
3. Is there a partner from a previous relationship who is making you feel unsafe 
now? 
 
A positive screen is a ‘yes’ response to Question 1 (with indication of perpetrator as 
fitting intimate partner definition) or a ‘yes’ response to Question 3, or a ‘no’ response to 
Question 2.  
 
Referral information on IPV services.  Women screening positive for IPV in arm 1 as 
well as all women in arm 2 will receive information on local IPV services. The printout 
(see appendix) will refer women to the Cook County Bureau of Health Services IPV 
program (Hospital Crisis Intervention Program or HCIP) as well as other off-site Chicago 
referral options.  The HCIP, located on the first floor of Fantus, is the domestic violence 
training and advocacy program at Cook County Hospital.  HCIP is a collaboration 
between the Chicago Abused Women Coalition (CAWC) and the Cook County Bureau of 
Health Services. A forerunner program located in an inner-city public hospital, HCIP has 
been hailed as a national model for hospital-based domestic violence services and 
training. HCIP provides direct services to victims of abuse that include crisis 
intervention, safety assessment and planning, individual counseling, information about 
their legal rights, court and systems advocacy, access to emergency shelter, financial 
assistance and referrals to other needed resources.   
                                                 
45 Feldhaus, KM, Koziol-McLain, J, Amsbury, HL, Norton, IM. Accuracy of 3 Brief 
Screening Questions for Detecting Partner Violence in the Emergency Department. 
JAMA 1997; 277: 1357-1361. 
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Each year, HCIP responds to approximately 700 referrals from clinicians and provides 
over 900 hours of direct services to over 400 clients. HCIP’s advocates are currently 
available Monday through Friday, 8:00 am to 9:00 pm. Services are provided in English 
and Spanish by a multicultural staff that has received extensive training in domestic 
violence advocacy, racism and oppression and available resources. HCIP’s staff is 
comprised of four full-time domestic violence advocates, one full-time direct services 
coordinator and a full-time co-director, all of whom are employed by the Chicago Abused 
Women Coalition (CAWC), the oldest domestic violence agency in Chicago.     
 
In order to avoid identifying women who screen positive for IPV to others in the clinic, 
women screening negative in arm 1 and all women in arm 3 will also receive a computer 
printout. This printout will contain a list of local health resources for women (please see 
appendix). 
 
Outcome variables   
 
a. Quality of Life (QOL): will be measured with the SF-1246 at both baseline and at the 
one-year follow-up (section A of baseline and follow-up). This 12-item tool was 
shortened from the SF-36 to maximize efficiency and best reflect the physical and mental 
health subscale scores.  This 12-item instrument has demonstrated ability to detect 
change in health status over periods of one year, including recovery from depression as 
well as physical health. The administration time is approximately 2 minutes. The SF-12 
includes 12 questions that measure overall health (1 item), physical functioning (2 items), 
role limitations due to physical health problems (4 items), bodily pain (1 item), 
energy/fatigue (1 item), social functioning (1 item), and psychological distress and well 
being (2 items; see questionnaire, section). This measure has shown acceptable reliability 
and validity32, and summary scores of the SF-12 can be used to derive a utility value for 
the health state reported through an established algorithm. This transformation of the 
SF12 score represents what the general population believes is the quality of life 
associated with each woman’s health state and allows comparisons with other conditions 
similarly standardized. This tool has been successfully and extensively used to assess 
QOL in clinical trials, and is amenable to CASI format.   
 
b. Mortality: Two of five women murdered in the US are murdered by an intimate partner 
resulting in over 1,100 deaths among women yearly.47 As such, the potential impact on 
mortality of the two interventions proposed in this trial is of interest. We will obtain two-
year mortality data from the Illinois Department of Health's Division of Vital Records.  
 
c. Disability will be assessed at both baseline and at the one-year follow-up utilizing the 
same time period. We propose two items to assess disability or inability to perform usual 
                                                 
46 Ware JE, Kosinski M, Keller SD.  A 12-item short-form health survey: construction of scales and 
preliminary tests of reliability and validity.  Med Care 1996;34(3):220-233. 
47 Cooper A, Smith, EL. Homicide Trends in the United States, 1980-2008. US Department of Justice, 
Bureau of Justice Statistics, 2011 (see spread spreadsheets for total number of deaths) Accessed January 25, 
2013 at: http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=2221. 
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 tasks over the past year (see questionnaires, section B at baseline and section C in follow-
up).  These two items assess days missed from work outside the home and days unable to 
perform usual household tasks and were used successfully in the WorldSAFE IPV 
study.48 
 
d. Utilization of health care services. The frequency and type of health service visits (i.e., 
hospitalizations, emergency room visits, and out-patient visits) will be assessed for the 12 
months previous to the baseline interview date and during the three years following 
enrollment and random assignment utilizing the Electronic Medical Record Database.  
Diagnoses based on ICD-9 codes will also be extracted for the three years following 
enrollment and random assignment to determine potential impact of the two interventions 
on morbidity presumed to be caused by IPV. We will review full medical records for a 
subsample of the first 15 participants recruited at each clinic to establish potential 
missing diagnoses not documented in the electronic records. All medical care encounters 
with any of the Bureau’s three hospitals and 31 clinics of the Cook County Bureau of 
Health Services are stored in this electronic medical record database.  This system 
captures >90% of all in- and out-patient service use in public system of Cook County. 
Participants will also be asked in the baseline and one-year follow-up surveys about 
hospitalizations and ED visits in the past year outside of the Bureau’s network (see 
questions in section C).  
 
e. Exposure to IPV: At one-year follow-up, all women will be asked about IPV exposure 
during their lifetime and, if answering affirmatively to any of the IPV questions, if they 
are currently with this partner or how long ago they separated from the most recent  
partner who was violent (please see section E of follow-up measures). These two 
questions will allow us to determine exposure to IPV in the past year and during the year 
before the intervention. To assess exposure to IPV, we will use 10 of the items measuring 
simple and aggravated assault (threaten and use a gun and threaten and use a knife or 
other weapon have each been collapsed into 2 items), one of the items measuring sexual 
assault, and the seven items measuring control utilized in the National Violence Against 
Women Survey (NVAWS).2 Factor analysis of the NVAWS data collected with the seven 
control items suggested that these items measured one construct reliably (Cronbach 
α=.70).49 These nonviolent control items will allow us to distinguish between situational 
couple violence (resulting when conflict escalates into mutually violent interactions) and 
so called “intimate terrorism” (male-to-female aggression motivated by the intent to 
control).50 Because these two types of IPV are hypothesized to have a different natural 
history and outcomes, the impact of any intervention might also differ. Once the 
interview has terminated, all respondents will be given the HCIP crisis line number and 
the 1-800 national IPV hotline in case they would like more information on IPV or would 
like assistance for themselves or someone they know. 
                                                 
48 Sadowski, LS, Hunter, WM, Bangdiwala, SI, Muñoz, SR. The world studies of abuse in the family 
environment (WorldSAFE): a model of multi-national study of family violence. Injury Control and Safety 
Promotion 2004; 11: 81-90. 
49 Johnson, MP & Leone, JM. The Differential Effects of Intimate Terrorism and Situational Couple 
Violence. Journal of Family Issues 2005; 26: 322-349. 
50 Johnson, MP & Ferraro, KJ. Research on domestic violence in the 1990s: Making distinctions. Journal of 
Marriage and Family 2000; 62:948-963. 
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f. direct costs of intervention: the additional costs incurred in arms 1 and 2 will be 
estimated based on start-up costs (computers, printers, acquisition and adaptation of 
existing programs for computer-assisted health screening, patient kiosks for privacy) and 
ongoing costs (space utilized, technical assistance required, participant time spent in IPV 
screening questions, printouts, and services utilized by the study participants. 
 
g. potential side effects of intervention.  
1) Beneficial effects (see section D of follow-up questionnaire): 
- Knowledge of the prevalence of IPV: Answer to the question: “If there were 10 
women sitting in a room, how many of these women would you guess have ever been 
physically, verbally, emotionally, or sexually threatened or harmed by an intimate 
partner.” Women responding between 2-3 will be categorized as having knowledge of 
the prevalence; those responding below 2 will be categorized as underestimating the 
prevalence and those responding above 3 will be categorized as overestimating the 
prevalence; 
- Knowledge of seriousness of IPV: perceived likelihood of physical and mental health 
problems among victims of IPV compared to non-victims. It will be considered 
beneficial if women respond that victims are more likely to have problems with their 
physical and mental health; 
- Knowledge of available services for victims of IPV: Reporting at least one local 
service in response to the question “Where can a woman who is being abused by an 
intimate partner get help in this community?”; 
- Attribution of responsibility for violence: Agreement or disagreement with the 
statement “Women usually get hit by their partners because of something they (the 
women) did”. It will be considered a benefit if women attribute responsibility to the 
perpetrator. 
- Perceived availability of services for IPV: Agreement or disagreement with the 
statement “Women who are abused by their partners can get help if they need it”.  
 
2) Adverse effects: Participants will be asked at the one-year follow-up if they 
experienced any problems as a result of their responding to our questions or receiving 
information as a participant in the study.  (Please see section F of follow-up 
questionnaire, #2 and 6). 
 
Mediating variables  
 
Contact with IPV resources: Women will first be asked if they remember receiving a list 
of names of agencies that provided help for women exposed to IPV on the date of their 
recruitment visit. If they do, they will be asked if they shared the list or contacted any of 
the agencies. They will also be asked if they had had any contact with this or any other 
IPV service before joining the study. (See Section F, #3-7 for these questions). 
 
Disclosure: Women answering affirmatively to any of the IPV questions (variable e), will 
be asked if they have discussed this (or these) experiences with anybody, and if 
affirmative, if this occurred before joining the study (See section E, #21). 
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Potential confounders 
a) Demographics: age, race/ethnicity, and insurance status will be based on information 
in the Cook County Bureau of Health Services Electronic Medical Record Database 
and educational level will be assessed during the follow-up interview (section G).  
b) Symptomatic/Asymptomatic: because evidence is needed that early treatment (during 
the asymptomatic period) produces better results than waiting for the appearance of 
symptoms and a diagnosis, we will establish the presence of signs or symptoms at 
baseline of conditions that have been associated with IPV51-52 (see section C of 
baseline measure) and explore potential effects in the asymptomatic group. 
c) Contamination: exposure to other health care providers who might screen or offer 
IPV resources will be assessed with the question “In the past year, has a doctor, nurse, 
or other health care provider ever asked you if you were afraid of a current or former 
intimate partner or if a current or former intimate partner had hurt or threatened you?” 
in the follow-up interview.  
d) Baseline mental health status, disability, quality of life, and utilization of health care 




Baseline data collection will take place at several separate locations within the Fantus 
Clinic as well as the CORE center, two sites within the Ambulatory Health Care 
Network, and the Rush- Presbyterian-St. Lukes Medical Center until the study sample is 
enrolled. The identification of potential participants and sampling procedure have been 
described previously (p.8). Women attending each site and called by the RA in the 
waiting room will be screened for eligibility (see sample script for eligibility in appendix) 
and, if eligible, invited to participate in this study, including the follow-up telephone 
interview one year later. The RA will offer women a copy of the consent form (please see 
Appendix) and will also read it aloud to her. Those consenting will be asked to go to a 
computer kiosk or private office with the RA and respond to the questionnaire on a touch 
screen computer. 
 
All baseline information except for age, race/ethnicity, health insurance status, and 
utilization of health care outside the Cook County Bureau of Health services will be 
based on self-report and collected at the time of recruitment using an audio-computer-
assisted structured interview (A-CASI). (See questionnaire in appendix). The A-CASI 
program will include the text of the question wording, response category wording, and 
the programming of the skip patterns, and range checks and other on-line consistency 
checks and procedures during the interview  
 
After recruiting eligible patients and completing informed consent procedures, the RA 
will activate the A-CASI program and assign the participant a unique identification 
                                                 
51 Campbell J, Jones AS, Dienemann J, et al. Intimate partner violence and physical health consequences. 
Arch Intern Med 2002; 162:1157-1163. 
52 Coker AL, Smith PH, Bethea L, et al. Physical health consequences of physical and psychological 
intimate partner violence. Arch Fam Med 2000;9:451-457. 
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 number. The participant will be randomized to one of the study arms using a computer-
generated random number generator. Randomization will be stratified by clinic and 
performed in permuted blocks to balance the number of participants for the study arms.  
If, for whatever reason, the participant does not complete the entire questionnaire, by 
using their unique study number, they will be able to restart the interview at their last 
completed question. Participants may skip questions if they choose. If they are 
interrupted and do not complete the questionnaire, they may continue where they left off. 
The RA who recruited the participant will have their unique study number and will key it 
into the computer when the participant is ready to resume the interview. 
If necessary, the laptop and printer are portable and can be moved from the office/kiosk 
to the health care provider’s exam room and completed while the patient waits for her 
provider. Research field staff will be available to assist women, if needed. It is estimated 
that, on average, the baseline questionnaire will take about 15 minutes to complete. 
 
Wrap-up session. RAs will meet with the participant they enrolled after she has 
completed her A-CASI.  During the wrap up, the RA will try to establish some rapport 
and negotiate telephone appointment dates/times for the one-year follow-up interview. 
She will ask participants to provide a preferred contact number, two alternate contact 
numbers, and the names and contact numbers of two people with whom she maintains 
regular contact. During this negotiation, the RAs will emphasize the woman’s 
convenience and safety.  Times not to call will be recorded in RAs’ log, as well as notes 
including agreed to safety signs (i.e., a safe word, identified by the woman to indicate if 
the woman is not able to safely answer the question). Additionally, during the wrap up, 
the RA will negotiate a safe message to leave on the participants’ voice mail or 
answering machine. The RAs will give each woman a card with the toll-free number and 
RA’s name noting the preferred time and two alternate times for the follow-up interview. 
The participant will be encouraged to inform the project of changes in her contact 
information by calling this 24-hour toll-free number. At the end of the wrap-up, the RA 
will discretely distribute the $10 compensation (unsealed envelope) and will note the time 
the woman has completed the study activities (and clinic visit). 
 
RAs will extract and input into participants’ study files demographics (age, 
race/ethnicity, pregnancy and health insurance status) and information on participants’ 
health care utilization in the past year (from baseline interview) from the Cook County 
Bureau of Health Services Electronic Medical Record Database.  
 
One-year follow-up interview. Participants will be contacted at least once by phone and 
possibly one or two more times by mail to remind them of the phone interview and verify 
contact information and plans for the next few months, and to review strategies agreed on 
at baseline for contact and ensure that these methods remain safe and appropriate. Eleven 
months after completion of the baseline interview, efforts will begin for the follow-up of 
participants and will continue up to 4 weeks after the one-year date. The same RA that 
enrolled the participant will be responsible for follow-up of that participant. RAs will 
schedule calls based on days and times participants’ reported preferring at baseline. All 
information, except selected demographics and health care utilization, will be collected at 
the one-year follow-up using a computer-assisted telephone interview (CATI). The RA 
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 will open the CATI application and enter the study identifier, log the date and time of 
contact. For patients who cannot be contacted on the initial attempt, the interviewer will 
attempt a follow-up call to each of the numbers the participant provided up to 4 times on 
3 consecutive days during times specifically negotiated with the women at enrollment, 
including calls during evening hours. After successful or failed follow-up contact, the 
patient will be removed from the report and considered as a failed contact. For partially 
completed or refused follow-up interviews the participant will be asked about the reason 
for termination of the interview (e.g., safety concerns or time pressures). The CATI 
program will create an automatic record of all dialings, track the outcome of each 
contact/interviewing attempt, and document reasons for refusal and the place of 
termination. 
 
Once contact with participants is established for the follow-up, the interviewer will either 
proceed with the interview or schedule the interview at a time convenient to the 
respondent. For patients who are unable to complete the interview, but who request the 
opportunity to resume the interview at a later date, work will be saved and the interviewer 
and interviewee will have the option of resuming the interview without repeating 
questions. This interview will take approximately 20 minutes to complete. Participants 
will receive a $15 gift certificate in the mail to compensate them for their time and effort. 
 
CATI follow up interviews will be conducted in the Collaborative Research Unit at 
Stroger-CATI office (Room 1608) following CRU protocol for attempts, response to 
disconnect, script for call answered by other, etc.)  The CATI program will include the 
text of the question wording, response category wording, and the programming of the 
skip patterns, and range checks and other on-line consistency checks and procedures 
during the interview as well as a system to help eliminate the problem of key entry error 
as a result of accidentally hitting the wrong key. For quality control, these activities will 
be supervised or reviewed by the study coordinator.  
 
To establish overall health care utilization and utilization by conditions presumptively 
related to IPV, we will extract data from Cook County Bureau of Health Services’ 
electronic medical records to establish the number and diagnoses using ICD-9 for 
ambulatory health care visits, emergency department visits, and hospitalizations at any 
County health care site occurring within a three year period from time of enrollment 
among the RCT of IPV Screening participants. A pilot query will be conducted on the 
first 15 participants enrolled in the trial at each clinic to compare diagnoses in the 
electronic medical record with a full medical record review. This will establish the 
magnitude and type of missing diagnoses in the electronic medical record and will 
attempt to account for the limited number of diagnoses that can be included in the 
electronic medical records. This pilot query will also help identify the set of variables to 
extract from the electronic medical record database in order to establish the number and 
diagnoses for ambulatory health care visits (excluding laboratory and radiology visits), 
emergency department visits, and hospitalizations at any County health care site. Data 
extracted from the electronic medical record database will be stored on a zip drive in an 
encrypted format. This database will be in an Access format and loaded onto a single 
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 stand alone PC and then de-identified (unique study ID #s only). Access to that PC will 
be limited and physical protections will be put in place. 
  
To establish overall mortality rates by study group and mortality rates by specific causes 
presumed to be consequences of IPV during the two years following enrollment and 
random assignment, we will submit participants’ name and date of birth to the Illinois 
Department of Health's Division of Vital Records. They will search their records to 
determine if a death has occurred and, if a death has occurred, they will provide a copy of 
the death certificate from which the immediate and underlying causes and manner of 
death will be abstracted. Death certificates will be kept in a locked file cabinet in a locked 
study office and access will be limited to 2 investigators and the project coordinator. All 
certificates will be destroyed once data are abstracted and analyses completed. 
 
Training and supervision of study personnel. All field staff (RAs) will have received 8-12 
hours of training by the Research Team. The content of training will include:  eligibility 
determination, recruitment, informed consent, enrollment, A-CASI operations, and CATI 
follow-up. In addition, interviewers will also receive information on IPV and its 
consequences and will receive instructions on what to do if a respondent reports exposure 
to IPV, if an incident occurs or a respondent asks for help during the CATI. 
Interviewers/RAs will not know at baseline if a participant is exposed to IPV unless the 
participant spontaneously reports this to her. Should this occur, interviewers will have 
been made aware during the training of three main principles in the management of 
persons who acknowledge partner violence or who ask for assistance around partner 
violence: (1) The safety of the individual and children; (2) Respect for the autonomy of 
the adult patient; and (3) Hold the perpetrator - not the survivor- responsible for the 
abuse. Based on these principles, interviewers will be instructed to remain calm and ask 
the participant if she would like to do something about the situation. If she chooses to do 
nothing about it at the moment, the interviewer will emphasize that services are free of 
charge and confidential, and provide the HCIP number as well as the interviewer’s 
number, should she change her mind. If the respondent says she would like to do 
something, the interviewer will ask about immediate safety concerns and whether the 
abuser is on the medical campus. If the abuser is on the campus then the interviewer will 
ask whether the participant wants the police to intervene or not. If the participant feels 
safe at the moment, the interviewer will ask if she would like counseling, in which case 
she will offer to call the HCIP or will provide the HCIP’s number so that the participant 
can make the call herself. Staff will be instructed to keep in mind that some women who 
answer yes may prefer to make a call themselves to a help line or the police without any 
assistance. In that case, staff will be instructed to provide a safe, confidential room for 
them to make a call at the medical center. If the participant does not want counseling at 
that time, staff will let her know that if she changes her mind, she can always contact a 
counselor at a later time and that we will tell her how to do so. 
 
Interviewers will be instructed to respond empathetically but nonjudgementally to 
participants who report exposure to IPV during the follow-up interview (e.g., “I see”, 
“That’s helpful for us to know”). In Q21 of Section F of the follow-up questionnaire, we 
ask if she has talked to anybody about these experiences and if she says “no”, we ask if 
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 she would like to talk to someone. If she does, the interviewer will say “at the end of our 
interview I will give you a number you can call.” If she does not, the interviewer will say 
“just in case you change your mind, at the end of our interview, I will give you a number 
you can call.” 
 
Telephone interviewing techniques will be modeled utilizing the study questionnaire and 
practiced by trainees through role-play. Trainees will be observed and given feedback 
during simulations of the interview until they are able to perform each skill to the PI’s 
satisfaction. 
 
Pilot study. Measures, methods, and procedures will be tested in a pilot study (presented 
in a separate protocol) to establish their feasibility and acceptability. The pilot study will 
compare health care provider screening, referral, and support to A-CASI screening and 
referral with different variations (i.e., with and without provider support or video clip 
support). The pilot will also provide estimates of our main outcome measures and the 
concordance between the two data collection methods proposed. Adjustments in 
screening and referral strategy, questionnaire items, sample size, or procedures will be 
made based on the results of this pilot study. Resulting modifications will be submitted to 
the IRB as an amendment. 
 
Data entry, cleaning, and management. Both the A-CASI and CATI programs will result 
in automatic data entry for most of our variables through the user interface and will 
automatically detect errors as a result of accidentally hitting the wrong key requiring the 
respondent/interviewer to confirm the entry. We anticipate that data entry will be directly 
into the SQL server database on the servers maintained by CRU and housed by the 
Hospital Information System Department.  If network connectivity is unsuccessful from 
some of the laptop locations, data entry will be automated into a Microsoft Access 
database, and data uploaded into the SQL server database.   
 
The terminal database will be Microsoft SQL server, which provides enhanced security 
protection beyond Access databases. The levels of protection include the firewall for the 
Department of Medicine, password-protected intranet access, and also password 
protection for access to the SQL server database. Database access will be restricted to 
members of the investigative team mentioned in this proposal. In addition, ad hoc access 
may be granted for research personnel who are added to the project. Locally stored 
Access databases will be erased after verifying the data were successfully uploaded to the 
SQL server. These data will be maintained on the SQL server database until publications 
are completed. 
 
Data extracted from the electronic medical record database for the three-year follow-up 
of morbidity will be stored on a zip drive in an encrypted format. This database will be in 
an Access format and loaded onto a single stand-alone PC and then de-identified (unique 
study ID #s only). Access to that PC will be limited and physical protections will be put 
in place. Number and ICD-9 codes of hospitalizations and ambulatory care visits 
occurring within the three-year follow-up window will be abstracted and entered into the 
SQL server database and then merged with the study database. 
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Death certificates obtained for the two-year follow-up will be kept in a locked file cabinet 
in a locked study office and access will be limited to 2 investigators and the project 
coordinator. Immediate and underlying causes and manner of death will be extracted and 
added to the study database. All certificates will be destroyed once data are abstracted 
and analyses completed. 
 
Data analysis plan 
 
Data will be extracted and analyzed with SPSS and STATA directly from the CASI or 
CATI systems. Two-year mortality and three-year morbidity data will be added to the 
study database once collected. 
 
Sample description and comparability across groups. Univariate and bivariate (i.e., 
measures of association) techniques will be used (e.g., frequencies, Fischer’s exact, chi-
square and t tests) as appropriate to cell size and type of variable to describe participants 
overall, and in each group to establish potential differences between groups as to 
confounders (sociodemographics,  baseline QOL, disability, and health care utilization).   
 
Impact of intervention: If there are no significant differences between groups on the 
selected confounders, a one-way analysis of variance will be conducted to establish 
differences in means among the two intervention and control groups and percentages will 
be used to establish differences between categorical variables. If there are differences in 
confounders between groups, multivariate techniques will be used to control for these 





Findings from this study will be disseminated through publications in professional 
journals.   
 
PROTECTION OF HUMAN SUBJECTS- ADDITIONAL INFORMATION 
 
Potential risks and methods to minimize risks 
 
We expect the occurrence of adverse effects as a result of this trial to be minimal and 
comparable to those encountered by individuals in the course of their daily lives given 
that the proposed assessment measures and the intervention (screening/referral) have 
been previously used in the general population with no reported consequences. 
Nevertheless, we have considered the following potential risks: 
 
Presence of partner or other accompanying companions at time of recruitment: To 
eliminate this risk, RAs will ask any companions to remain in the waiting room to 
maintain the participants’ privacy. If this is not possible, the patient will not be allowed to 
participate in the study. 
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Presence of other household members during the telephone interview: To minimize this 
risk, before initiating the interview but after reminding the participant of the objectives of 
the study and content of the interview, the respondent will be asked if she can speak 
comfortably at that time. The interviewer will also ask the respondent to say, “I am 
busy”, if at any time during the interview they feel they are no longer able to speak 
openly and confidentially. Interviewers will be trained to detect signs that may indicate 
the respondent is uncomfortable in which case she will again ask if this is a good time to 
talk and if the respondent feels completely comfortable talking at that time. If there is any 
doubt, arrangements will be made to call back at a time suggested by the respondent.  
 
Respondent is upset by the questions. It is possible that participants may feel emotionally 
uncomfortable responding to some of the questions. At time of enrollment, participants 
will be informed that they may skip any question they do not wish to answer, and that 
they are free to withdraw at any time. At wrap-up of enrollment session, RAs will ask 
participants how they are and if a participant feels distressed or appears distressed, the 
field supervisor will be available to talk to her. For the CATI, interviewers will be made 
aware of the sensitive nature of the questions during training and will be taught to 
respond respectfully and empathetically. The HCIP number and the National Domestic 
Violence Hotline number will be provided to all interviewees should they desire help for 
themselves or someone they know. 
 
Occurrence of IPV during an interview. The chances of this event occurring during this 
20-minute interview are very low. However, to further minimize this risk, interviewers 
will have taken the necessary precautions to make sure other members of the household 
are not present during the interview (see section on Presence of other household members 
during the interview above). In addition, if an interviewer hears noise (i.e., an adult 
speaking loudly or shouting in anger) that alert her to the possibility of a problem, they 
will instruct the respondent to hang up and call someone if they think they need help, or if 




The proposed interventions may be of benefit to some participants, and even if the 
interventions do not directly benefit participants, the findings will help CDC, IPV 
advocacy groups, and health care providers make informed decisions about the usefulness 
of universal screening in primary care.  
 
The telephone interview might generate awareness and interest around the issue of IPV. 
All interviewees will be given the local as well as the city of Chicago Domestic Violence 
Hotline number should they know of anybody who might need some assistance or if they 
personally would like more information or assistance.  
 
Procedure for obtaining informed consent 
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 Patients verified to be eligible for enrollment will undergo the process of informed 
consent with a trained research assistant. The consent script has been written at a 7.9 
grade level, based on the Flesch-Kincaid Readability Test. It will be read slowly to the 
respondents by the RA. In the consent script, the RA will describe the purpose, content, 
and length of the interview; alert the respondent that the survey contains sensitive 
questions but that the participant may choose not respond to any or all questions; assure 
the respondent that the information she provides will remain confidential; that 
participation is voluntary, and that she will be assigned randomly to one of three groups. 
Potential participants will be given an opportunity to ask questions or have something 
they did not understand clarified and will be offered a copy of the consent form if they 
feel it would not put them at risk. Respondents will be given a toll free phone number to 
contact the PI in the event they have questions regarding the study or the agency and a 
local and CDC Human Subjects number if they wish information on their rights as human 
subjects. (See consent script in Appendix). Patients who choose not to participate will 
receive the usual standard of care.  
 
Provisions for protecting confidentiality 
 
Identifying information will be collected during the wrap-up for one-year follow-up, 
however, only an identification number will link this information to the respondents’ 
answers on the A-CASI and CATI and will not be stored in the same database. All 
identifiers with the exception of the study identification number will be removed from the 
study file once the follow-up interview is completed and linked to the baseline interview. 
All personnel, from recruiters to project director, will be required to sign confidentiality 
pledges. Signed consent forms and receipts of incentive payments will be kept in a locked 
file cabinet in a locked office, accessible only by the investigators and other research 
staff. Project staff will be vigilant of laptop computers while they are being used. 
Electronic files with the baseline and one-year follow-up interviews will be secured in 
computers that are password protected and kept in a locked office when not in use. The 
physical security of the data will be ensured by the location of file servers, tapes, and tape 
backup units in locked areas. Diskettes and other backup materials will also be stored in 
locked files. Contact information will be stored in lockable file cabinets.  
 
Data extracted from the electronic medical record database for the three-year follow-up 
will be stored on a zip drive in an encrypted format. This database will be in an Access 
format and loaded onto a single stand alone PC and then de-identified (unique study ID 
#s only). Access to that PC will be limited and physical protections will be put in place. 
 
Death certificates obtained for the two-year follow-up will be kept in a locked file cabinet 
in a locked study office and access will be limited to 2 investigators and the project 
coordinator. All certificates will be destroyed once data are abstracted and analyses 
completed. 
 
Handling of Unexpected or Adverse Events 
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 Problems or unanticipated events arising during the recruitment interview or follow-up 
interview will be detected by field staff and recorded in their daily logs. These will be 
reviewed each day by the supervisor to identify and solve any emerging problems.   
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 Recruitment Flyer- ENGLISH 
 
Would you like to volunteer for a study  
while you wait for your doctor or after you see your doctor today? 
 
We are trying something new -asking health questions on easy-to-use 
computers. 
The computers can be used while you are waiting for your appointment(s) or 
medicine refills.   
You do not need to have any computer skills.   
You will listen thru headphones and touch the screen with your finger to 
answer the questions.   
Your time with your doctor will not be affected. 
For this study, the computer will ask questions about women’s health. 
If you are interested in knowing more – please place this paper in the bin on 
the reception desk. The bin is near the battery container and labeled 
"Women’s Health and Computer Study”. 
You will receive compensation for your time. 
If you are not interested, you may give this paper to the receptionist when 
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 Recruitment Flyer- SPANISH 
 
¿Le gustaría ser una voluntaria para un estudio  
mientras espera a su médico o después de ver a su médico hoy? 
 
Estamos intentando algo nuevo - hacer preguntas de salud en computadoras 
que son fáciles de usar. 
Las computadoras pueden ser utilizadas mientras espera su cita(s) o el 
surtido nuevo de medicamentos. 
Usted no necesita tener ninguna habilidad con la computadora. 
Usted escuchará por audífonos y tocará la pantalla con su dedo para 
contestar las preguntas. 
Su tiempo con su médico no será afectado.  
 
Para este estudio, la computadora le hará preguntas sobre la salud de las 
mujeres. 
 
Si usted está interesada en saber más - por favor ponga esta hoja en la 
bandeja del escritorio de recepción. La bandeja está cerca del recipiente de 
batería y marcado "Estudio Sobre la Salud de las Mujeres por 
Computadora". 
 
Usted recibirá compensación por su tiempo. 
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 Script for Eligibility 
 
Hi, I’m _________________. I work for the Research Collaborative Unit at Stroger 
Hospital.  
 
Do you speak English?  
(If no)  Spanish?  
(If no) That’s o.k. Thank you. STOP 
(If yes)  Muy bien. Gracias. Estamos haciendo un estudio sobre la salud 
de las mujeres. Tiene acceso a un teléfono a donde la podemos 
llamar para hacerle unas preguntas? 
(If no)  No importa. Gracias. STOP 
(If yes)  Muy bien. Gracias.  
 
(If yes)  Great. Thank you. We’re doing  a study on women’s health. 
Do you have access to a phone where we can call you to ask you some questions? 
  (If no)  That’s o.k. Thank you. STOP 
(If yes)  Good. Thank you.  
 
Research Assistant will determine, by observation, if patient is ineligible because of 
visual, hearing, or mental impairment; or accompanied by a child over age three with no 
other adult supervision or a companion who refuses to separate from her.  
 
(If not eligible) Patient will be thanked. 
(If eligible) We’d like to invite you to participate in our study/Queremos invitarla a que 
participle en este studio.  (Continue with consent form). 
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 INFORMED CONSENT FOR RESEARCH 
Women’s Health and Computer study 
 
INTRODUCTION 
This is to ask you to be in a research study. This study is to find out if asking women 
about their health and giving information on what to do about certain risks can improve 
women’s health. Doctors and their staff at John H. Stroger Hospital are doing this study. 
The study is being sponsored by the Centers for Disease Control and Prevention (CDC). 
 
WHAT WILL I BE ASKED DO IF I AM IN THE STUDY? 
Being part of the study means that: 
1. You will be put in one of 3 options. If you decide to be in this study you will be 
put into one of the options by chance, like flipping a coin. Neither you nor the 
study staff may choose which option you are in.  
2. You will hear and read questions on a computer in each of the 3 options and 
answer by touching the screen. The interview will last anywhere from 15-30 
minutes and will take place in the clinic. In all 3 groups, the computer will ask 
you questions about your physical and mental health, the number of days that you 
were too ill to work, how often you use health care services, and questions on 
how to best contact you. The difference between the 3 options is that in some you 
may be asked about your experiences with violence and in some you may be 
given information on useful resources for dealing with health problems, including 
violence. Research staff will be available to help you if you have any questions or 
need help with the computer. 
3. In a year, we will call you to ask you some of the same questions again over the 
phone. That interview will take about 20 minutes and will include questions on 
your experiences with violence. You can call us at 1-312-864-3684 at a time that 
is best for you. We can also call you if you would like. In addition, we will try to 
contact you at least once and possibly one or two more times to remind you about 
the phone interview. We would do this by either calling you or sending reminders 
in the mail. We will refer to this study as the “Women’s Health and Computer 
Study” when we contact you.  
 
WHAT ARE THE RISKS OF BEING IN THIS STUDY 
You will be asked questions about your physical health, emotional health, ability to work, 
and your experience with partner violence. This may cause you to be upset. You will be 
interviewed 1 year later by phone and you will be asked if there is enough privacy to be 
sure that your answers are not heard by other members of your home. Members of your 
home may also know about the reminder calls or mailings. We are asking for your 
permission to review your medical records.  In addition, there is a small chance of 
possible loss of privacy, but we have strict procedures to prevent that from happening. 
Your answers will not have your name on them but will have a code number to keep your 
answers separate from everybody else’s. Your answers to these questions will not be 
shared with anyone outside of the study team.  
 
Downloaded From: http://jama.jamanetwork.com/ by a Stephen B. Thacker CDC Library User  on 12/22/2015
 We keep all information locked in our offices and you will never be identified in any 
report. We will keep your records private as much as allowed by law. Your name and 
other facts that might point to you will not appear when we present this study or publish 
its results.  
 
Officials from the hospital or the government may check the records to make sure your 
rights are protected. 
 
WHAT ARE THE BENEFITS TO TAKING PART IN THIS STUDY 
We hope that being in the study will be good for you, however we don’t know if this will 
be the case. We hope that this study will show us better ways to ask women in clinics 
about their health.  
 
 
WHY WOULD THE DOCTORS TAKE ME OFF THIS STUDY EARLY? 
The study doctors may stop you from taking part in this study at any time if they decide it 
is in your best interest, if they decide it is dangerous for you to continue, or if the study is 
ended.  
 
WHAT ARE MY RIGHTS AS A RESEARCH PARTICIPANT? 
You can choose freely not to be in this project. The decision is up to you. The project 
begins in the clinic after you agree to participate and ends once all the study information 
is collected. You have the right to refuse to answer any of the questions during the 
interviews or stop the interview at any time. You have the right choose the best time for 
the phone interview. 
 
If you choose not to be in the project, you will receive the care that you and your doctor 
agree on. You can also drop out of the project at any time without penalty. 
 
 
WHAT ARE THE COSTS TO ME? 
There is no cost for the study related activities. 
 
 
WILL I RECEIVE ANY COMPENSATION? 
For your time and effort, each person in the project will be given $20 after the first 
interview is completed. You will then be mailed a $15 money order, 1 year later, after the 
phone interview is completed. 
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 ___ The study has been explained to me, and I agree to take part in the study on women’s 
health. 
___ I know that I have a choice. I can choose not to be in the study, and I can choose 
to stop at any time during the study. 
 
Participant’s Name: (Please Print) _____ 
Participant’s Signature:   
Date:    
 
Person who read the consent form, explained the study in detail, and answered all 
questions to the subject’s complete satisfaction: 
Name: (Please Print)   







You can choose to receive a copy of this form or we can just give you information on 
how to contact us if you have any questions.  
 
WHAT DO I DO IF I HAVE ANY QUESTIONS OR PROBLEMS 
You can call the project staff at 1-312-864-3684. You can leave a message here Monday-
Friday 9-5 and someone will get back to you. 
 
You can also speak with any of the following doctors: 
 
Romina Kee  312-864-3630    Doctor, Co- Investigator 
Sabrina Kendrick    312 -572-4710               CORE Center    Doctor 
Laura Sadowski  312-864-3646    Doctor, Principal Investigator 
 
In addition, you can contact the Quality Coordinator (Funeka Sihlali) about your rights as 
a participant or if you feel that you have been harmed in any way at 312-864-4821 during 
business hours or the CDC Human Research Protection Office at 1-800-584-8814. For 
the CDC, leave a brief message with protocol number 4985, your name, and phone 
number, and you will be called back as soon as possible. 
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 SPANISH VERSION OF CONSENT FORM 
 
CONSENTIMIENTO INFORMADO PARA INVESTIGACIÓN 




Esto es para pedirle que sea parte de un estudio. El propósito de este estudio es para saber 
si preguntándole a las mujeres sobre su salud y dándole información sobre qué hacer 
frente a ciertos riesgos mejora su salud. Los doctores y su personal en el hospital de John 
H. Stroger están haciendo este estudio. El estudio está siendo patrocinado por los Centros 
para el Control y la Prevención de Enfermedades (CDC).   
 
 
¿QUÉ TENGO QUE HACER SI ESTOY EN EL ESTUDIO? 
Ser parte del estudio significa que: 
1. Usted será asignada a una de 3 opciones. Si usted decide estar en este estudio, 
usted será asignada a una de estas opciones al azar, como echar una moneda a 
cara o cruz. Ni usted ni el personal del estudio puede elegir a cual grupo será 
asignada. 
2. Escuchará y leerá preguntas en una computadora en cada uno de las 3 
opciones, y contestará tocando la pantalla. La entrevista durará entre 15-30 
minutos y ocurrirá en la clínica. En los 3 grupos, la computadora le 
preguntará acerca de su salud física y mental, el número de días que no pudo 
trabajar por incapacidad, la frecuencia con que usted utiliza los servicios de 
asistencia médica, y preguntas sobre la mejor manera de contactarla. La 
diferencia entre las tres opciones es que algunos quizás se le preguntará sobre 
sus experiencias con la violencia y en otros quizás se le dará información 
sobre los recursos útiles para hacerle frente a los problemas de salud, 
incluyendo la violencia. Personal del estudio estará disponible para ayudarle 
por si tiene preguntas o necesita ayuda con el computador. 
3. En un año, le haremos algunas de las mismas preguntas por teléfono. Esa 
entrevista tomará cerca de 15-20 minutos e incluirá preguntas sobre su 
experiencia con la violencia. Usted también puede llamarnos al 1-312-864-
3684 a una hora que le conviene. O si prefiere, nosotros la podemos llamar. 
Durante el año, nosotros trataremos de contactarla por lo menos una vez y 
posiblemente una o dos veces más para recordarle sobre la entrevista por 
teléfono.  Haremos esto ya sea llamándole o enviándole recordatorios por 
correo. Nos referiremos a este estudio como el “Estudio Sobre la Salud de las 






¿CUÁLES SON LOS RIESGOS  DE SER PARTE EN ESTE ESTUDIO? 
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 Le harán preguntas sobre su salud física, salud emocional, capacidad de trabajar, y su 
experiencia con la violencia de pareja. Esto puede causarle molestia. Usted será 
entrevistada 1 año después por teléfono y hay un riesgo que otros miembros de su hogar 
puedan oír por casualidad sus respuestas. Los miembros de su hogar también pueden 
saber sobre las llamadas o los recordatorios por correo. También le estamos pidiendo su 
permiso para revisar sus expedientes médicos. Hay una pequeña posibilidad de la posible 
pérdida de privacidad pero tenemos procedimientos estrictos para prevenir que eso vaya a 
suceder. Sus respuestas no tendrán su nombre en ellas pero sí tendrán un número de 
código para mantener sus respuestas separadas de todas las demás. Sus respuestas a estas 
preguntas no serán compartidas con otros fuera del estudio.   
 
Mantenemos toda la información asegurada en nuestras oficinas y nunca será identificada 
en ningún informe. Mantendremos su información en privado hasta donde la ley no lo 
permite. Su nombre y otros hechos que podrán identificarla no aparecerán cuando 
presentamos este estudio o publicamos los resultados. 
 
Los oficiales del hospital o del gobierno pueden verificar los expedientes para asegurar 
que sus derechos están protegidos. 
 
¿CUÁLES SON LOS BENEFICIOS DE SER PARTE EN ESTE ESTUDIO? 
Esperamos que el estar en el proyecto sea bueno para usted, pero no sabemos si esto será 
el caso. Esperamos que este estudio nos muestre mejores maneras de preguntarles a las 
mujeres en las clínicas sobre sus asuntos de salud. 
 
¿POR QUE LOS DOCTORES ME TOMARIAN DE ESTE ESTUDIO TEMPRANO? 
Los doctores del estudio pueden parar su participación en este estudio en cualquier 
momento si ellos deciden que está en su mejor interés, si deciden que es peligroso para 
usted continuar, o si el estudio se termina. 
 
¿CUÁLES SON MIS DERECHOS COMO PARTICIPANTE EN LA 
INVESTIGACIÓN? 
Usted puede elegir libremente no estar en este proyecto. La decisión es suya. El proyecto 
empezará en la clínica después de que usted esté de acuerdo en participar y terminará 
cuando toda la información del estudio sea recolectada. 
 
Usted tiene el derecho de negarse a contestar cualquier pregunta durante las entrevistas o 
de parar la entrevista en cualquier momento. Usted tiene el derecho de elegir el mejor 
momento para la entrevista por teléfono. 
 
Si usted elige no estar en el proyecto, usted recibirá el cuidado que usted y su doctor 
acuerden. Usted también puede retirarse del proyecto en cualquier momento sin castigo. 
 
¿CUÁLES SON LOS COSTOS PARA MÍ?  
No hay costo para las actividades relacionadas al estudio.  
 
¿VOY A RECIBIR ALGUNA COMPENSACIÓN? 
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 Por su tiempo y esfuerzo, cada persona en el proyecto recibirá $20 después de que la 
primera entrevista se ha completado. Luego se le enviará un giro postal de $15, 1 año más 
tarde, después de que la entrevista por teléfono se ha completado. 
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 ____ Se me ha explicado el estudio, y estoy de acuerdo en tomar parte en el estudio 
sobre la salud de las mujeres. 
 
____ Sé que puedo elegir.  Puedo elegir no estar en el estudio, y puedo elegir parar 
en cualquier tiempo durante el estudio. 
 
 
Nombre del Participante: (Favor de usar letra de imprenta) _________________________________ 
 
Firma del Participante: ___________________________________________________________ 
 
Fecha: ________________________________________________________________________  
 
 
Persona que leyó el consentimiento, explicó el estudio en detalle, y contestó todas las 
preguntas a la satisfacción completa del participante: 
 
Nombre: (Favor de usar letra de imprenta) ______________________________________________ 
 





Usted puede elegir si recibir una copia de este consentimiento o le podemos dar la 
información sobre cómo contactarnos si usted tiene algunas preguntas. 
 
  
¿QUÉ HAGO SI TENGO ALGUNAS PREGUNTAS O PROBLEMAS? 
Usted puede llamar el personal del proyecto al 1-312-864-3684. Puede dejar un mensaje 
aquí de lunes-viernes de 9-4 y alguien se pondrá en contacto con usted. 
 
También puede hablar con cualquiera de los siguientes doctores: 
 
Romina Kee            312-864-3630  Ob/Gin              Doctora 
Sabrina Kendrick       312-572-4710 Centro CORE Doctora 
Laura Sadowski         312-864-3646 Atención Primaria Doctora, Investigadora Principal 
 
 
En adición, puede contactar a la Coordinadora de Calidad (Funeka Sihlali) acerca de sus 
derechos como participante al 312-864-4821 durante las horas de oficina, lunes-viernes, o 
llamar a la Oficina de Protección del Participante en la Investigación del CDC al 1-800-
584-8814. Para el CDC, deje un breve mensaje con el número del protocolo # 4985, su 
nombre, y el número de teléfono, y alguien le devolverá la llamada lo mas pronto posible. 
 
 




Printouts for IPV (+) and IPV (-) women
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 Our patients have found these places to 
provide helpful health and social services 
to those who live in Cook County. 
 
List of contacts 
Stroger Hospital Crisis Intervention 
(HCIP)…………………….312-864-1095 
 
Humboldt Park Outreach Program 
(HPOP)..………………….773-489-9081 
 
National Domestic Violence 24hr Hotline 
(Toll Free)……1-800-799-SAFE 
 
Chicago Domestic Violence Helpline  
(Toll Free)...............….....877-863-6338 
 
IL Domestic Violence 24hr Hotline  
(Toll Free) ……………1-800-603-HELP 
 
City of Chicago24 hr Suicide Hotline 
(Toll Free)………..……1-800-273-TALK 
 
Chicago Department of Human Services 
(Toll Free)…1-800-654-8595 
 
Chicago Department of Health 
…………………………….312-744-5000 
 













Action for Children………773-687-4000 
 
Howard Area Community Center 
…………………………….773-262-6622 
 
Metropolitan Family Services 
…………………………….312-986-4000 
 






National Alliance for the Mentally Ill 
(Toll Free)…………...…1-800-950-6264 
 





Mujeres Latina en Acción 
…………………………….773-890-7676 
 





Cook County State’s Attorney/Victim 
Witness Assistance……..773-869-7200 
 






Apna Ghar……...(North) 773-334-0173 
………………..…(South) 773-334-4663 
 






Crisis Center South Suburbia 
………………………........708-429-7233 
 
Elgin-Battered Women’s Shelter 
…………………………….847-697-2380 
 





Alcohol/Drug Treatment Services 
Alcohol/Drug 24hr Helpline 
(Toll Free)……………...1-800-821-4357 
 







Gateway Foundation …..773-890-5667 
 
Cornell Intervention… …773-737-4600 
 
New Horizon Rehab …..773-261-6663 
 
Association House………773-772-8009 
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 Our patients have found these places 
to provide helpful health and social 
services to those who live in Cook 
County. 
 







Rush University Medical Center 
….……………………….312-942-5000 
Chicago Dept of Health 
…………………………….312-744-5000 
 
Illinois Department of Human Services 
(Toll Free)….……..……1-800-843-6154 
 
Chicago Department of Human 
Services (Toll Free)......1-800-747-0200 
 
Infant Welfare Society…..773-728-2800 
 





Cook County State’s Attorney/Victim 
Witness Assistance……..773-869-7200 
 





Rainbow House Outreach Center 
(Toll Free)..…………….1-800-913-0065 
 





Community Counseling Centers of 
Chicago.………………….773-769-0205 
 








Howard Area Community Center 
…………………………….773-262-6622 
 
Metropolitan Family Services 
…………………………….312-986-4400 
 




Alcohol/Drug Treatment Services 
Alcohol/Drug 24hr Helpline 
(Toll Free)……………...1-800-821-4357 
 
















Apna Ghar……...(North) 773-334-0173 
………………..…(South) 773-334-4663 
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 Baseline Measures 
 
A. Quality of Life: SF-12 Health Survey (Ware, Kisinski, & Keller, 1996) 
 
These first questions ask about your health and how well you get along in your usual 
activities.  For each question please touch the one box the best describes you. 
 
Delayed CASI response for patients who haven’t answered within 5 seconds of 
completion of question: “If you are unsure about how to answer, please choose 
the box that seems best for you.” 
 
1. In general, would you say your health is: 
 
Excellent Very good  Good  Fair  Poor 
 
 
Now a list of activities you might do in a typical day will be read. As each item is read, 
please indicate if your health now limits you a lot, limits you a little, or not at all in these 
activities. 
 
               Yes,   Yes   No, not 
2. Moderate activities such as moving a table,    limited      limited limited at all 
pushing a vacuum cleaner?        a lot  little 
        
 
3. Climbing several flights of stairs?   
 
The following 2 questions ask about your physical health and your daily activities.  
 
4. During the past 4 weeks, how much of the time have you accomplished less than you 
would like as a result of your physical health? 
 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time         
5. During the past 4 weeks, how much of the time were you limited in the kind of work or 
other regular daily activities as a result of your physical health? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time  
 
The next 3 questions ask about your emotions and your daily activities. 
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6. During the past 4 weeks, how much of the time have you accomplished less than you 
would like as a result of any emotional problems (such as feeling anxious or depressed)? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time  
 
7. During the past 4 weeks, how much of the time did you do work or other daily 
activities less carefully than usual as a result of any emotional problems (such as feeling 
anxious or depressed)? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time  
 
8. During the past 4 weeks, how much did pain interfere with your normal work 
including both work outside the home and housework? 
 




These questions are about how you feel and how things have been with you during the 
last 4 weeks. For each question, please give the one answer that comes closest to the way 
you have been feeling. How much of the time during the last 4 weeks: 
       All of       Most of      A good       Some of      A little      None of 
     the time     the time        bit of         the time        of           the time 
           the time                        the time 
9.  Have you felt  
    calm and peaceful?    
 
10. Did you have a lot  
    of energy? 
 
11. Have you felt  
    downhearted and  
    blue? 
 
12. During the last 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your usual activities (like visiting friends, relatives, etc.)? 
 
All of the time       Most of the time          Some of the time     A little  of     None of the  
                        the time             time 
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1. During the 30 days from { date from 30 days before baseline interview to baseline 
interview }, about how many days did you miss work because of an illness or injury (do 
not include maternity leave)? If patient delays answer, audio cues for patient to give best 
guess. 
 
____  days 
____  Don’t remember 
____  Don’t work outside the house 
 
2. During the 30 days from { date from 30 days before baseline interview to baseline 
interview }, about how many days were you unable to do your housework tasks because 
of an illness or injury (do not include maternity leave)? 
____  days 
____  Don’t remember 
 
 
C. Current signs or symptoms 
 
Are you frequently bothered by any of the following 
problems? 
   
1. Arthritis or pain, aching, stiffness, or swelling in or 
around a joint (knee, elbow, hip, fingers, etc.) 
YES NO  
2. Neck pain or low back pain YES NO  
3. Stomach or abdominal pain YES NO  




5. Pain or problems during sexual intercourse YES NO I am not 
having sex 
now
6. Vaginal bleeding that is not normal  YES NO  
7. Vaginal or genital infection or any kind of discharge YES NO  
8. Headaches or migraines YES NO  
9. Nausea, gas, or indigestion YES NO  
10. Constipation YES NO  
11. Vomiting or diarrhea YES NO  
12. Trouble falling asleep or staying asleep on 3 or more YES NO  
Downloaded From: http://jama.jamanetwork.com/ by a Stephen B. Thacker CDC Library User  on 12/22/2015
 nights a week. 
 
 
D. Health Care Utilization outside Bureau  
 
1. During the past 12 months, have you stayed at least one night – not just in an 
emergency room  hospitalized in a hospital or clinic other than at Stroger or Rush?  




2. During the past 12 months, have you gone to an Emergency Department Room other 
than at Stroger or Rush? 
___ Yes  How many times were you in an emergency room other than Stroger or 
Rush? ____ 
 Were any of these times because of an injury (like a cut, burn, fracture, 





F. Partner Violence Screen  (Feldhaus, et al., 1997) ONLY IN ARM 1 
 
These next questions refer to violence by intimate partners. Violence is a problem for 
many women. Because it affects their health, we are asking our patients about it. Just so 
you know, your answers will not be shared with anyone unless you choose to share them. 
 
1. Have you been hit, kicked, punched, or otherwise hurt by an intimate partner within 
the past year? 
__ YES 
__ NO 
2. Do you feel safe in your current relationship? 
__ YES 
__ NO 
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One-year Follow-up Measures 
 
A. Quality of Life SF-12 Health Survey (Ware, Kisinski, & Keller, 1996) 
 
These first questions ask about your health and how well you get along in your usual 
activities.  
 
1. In general, would you say your health is: 
 
Excellent Very good  Good  Fair  Poor 
 
 
Now a list of activities you might do in a typical day will be read. As each item is read, 
please indicate if your health now limits you a lot, limits you a little, or not at all in these 
activities? 
 
                  Yes,         Yes             No, not 
2. Moderate activities such as moving a table,  limited          limited limited at all 
pushing a vacuum cleaner              a lot  little 
         
 
3. Climbing several flights of stairs?   
 
 The following 2 questions ask about your physical health and your daily activities.  
 
4. During the past 4 weeks, how much of the time have you accomplished less than you 
would like as a result of your physical health? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time 
 
5. During the past 4 weeks, how much of the time were you limited in the kind of work or 
other regular daily activities as a result of your physical health? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time 
 
The next 3 questions ask about your emotions and your daily activities. 
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 During the {date from 30 days before baseline interview to baseline interview}, have you 
had any of the following problems with your work or other regular daily activity as a 
result of your emotional problems (such as feeling depressed or anxious)? 
 
6. During the past 4 weeks, how much of the time have you accomplished less than you 
would like as a result of your emotional problems (such as feeling anxious or depressed)? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time 
 
7. During the past 4 weeks, how much of the time did you do work or other daily 
activities less carefully as a result of your emotional problems (such as feeling anxious or 
depressed)? 
__all of the time 
__most of the time 
__ some of the time 
__ a little of the time 
__ none of the time 
 
8. During the past 4 weeks, how much did pain interfere with your normal work 
including both work outside the home and housework? 
 




These questions are about how you feel and how things have been with you during the 
last 4 weeks. For each question, please give the one answer that comes closest to the way 
you have been feeling. How much of the time during these dates: 
       All of       Most of      A good       Some of      A little      None of 
     the time     the time        bit of         the time        of           the time 
              the time                        the time 
9.  Did you feel  
    calm and peaceful?    
 
10. Did you have a lot  
    of energy? 
 
11. Have you felt  
    downhearted and  
    blue? 
 
12. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your usual activities (like visiting friends, relatives, etc.)? 
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All of the time       Most of the time          Some of the time     A little  of     None of the  
                        the time             time 
  




1. During the 30 days from {date from 30 days before follow-up interview to follow-up 
interview}, about how many days did you miss work because of an illness or injury (do 
not include maternity leave)? 
____  days 
____  Don’t remember 
____  Don’t work outside my home 
 
2. During the 30 days from {date from 30 days before follow-up interview to follow-up 
interview}, about how many days were you unable to do your housework tasks because 
of an illness or injury (do not include maternity leave)? 
____  days 
____  Don’t remember 
 
 
C. Health Care Utilization outside Bureau and exposure to screening  
 
1. During the past 12 months have you stayed at least one night in a hospital other than 
Stroger or Rush? 




2.During the past 12 months, have you gone to an Emergency Room other than Stroger or 
Rush 





3. In the past year, has a doctor, nurse, or other health care provider ever asked you if you 
were afraid of a current or former intimate partner or if a current or former intimate 
partner had hurt or threatened you? By intimate partner we mean a person you date, go 
out with, are romantically involved with, are married to, or live with as a couple. 
___ Yes 
___ No 
___ Doesn’t remember/Not sure  
 
D. Positive effects of intervention 
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These next questions ask for your opinions about abuse by an intimate partner. Don’t 
worry if you’re not sure of the answer. 
 
1. Please think about this situation: If there were 10 women sitting in a room, how many 
of these women would you guess have ever been physically, verbally, emotionally, or 
sexually threatened or harmed by an intimate partner?  
 ________(number, 0-10) 
 
2. How likely is it for women threatened or harmed by an intimate partner (compared to 
women who have not been threatened or harmed) to have problems with their physical 
health? More likely, less likely, or about the same? 
___ More likely 
___ Equally likely 
___ Less likely 
 
3. How likely is it for women threatened or harmed by an intimate partner (compared to 
women who have not) to have problems with their mental health such as anxiety, 
depression, or substance abuse? More likely, less likely, or about the same? 
___ More likely 
___ Equally likely 
___ Less likely 
 
4. Do you agree or disagree with this statement:  
“Women usually get hurt by their partners because of something they (the women) did”? 
___ Agree 
___ Disagree 
___ Not sure 
 
5. Do you agree or disagree with this statement: “Women who are hurt by their partners 
can get help if they need it”? 
___ Agree 
___ Disagree 
___ Not sure 
 
6. Where can a woman who is being hurt by an intimate partner get help in this 
community? (Do not provide options) 
___ HCIP 




E. Exposure to Intimate Partner Violence (NVAWS, 2000) 
 
Now we would like to know about your experiences with intimate partners. Just so you 
know, your answers will not be shared with anyone unless you choose to share them. 
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Has a person you dated, or became romantically involved with, or lived as a couple with 
ever:  
1. tried to limit your contact with family and friends?  YES NO 
2. been jealous or possessive?       YES NO 
3. insisted on knowing who you were with at all times?  YES NO 
4. called you names or put you down in front of others? YES NO 
5. made you feel inadequate?       YES NO 
6. shouted or sworn at you?       YES NO 
7. prevented you from having access to joint income?  YES NO 
8. thrown something at you that could hurt?    YES NO 
9. pushed, grabbed, or shoved you?      YES NO 
10. pulled your hair?         YES NO 
11. slapped or hit you?        YES NO 
12. kicked or bitten you?        YES NO 
13. choked or attempted to drown you?     YES NO 
14. hit you with some object?       YES NO 
15. beat you up?          YES NO 
16. used or threatened you with a knife?     YES NO 
17. used or threatened you with a gun?     YES NO 
18. made you or tried to make you have vaginal, oral or anal sex?   YES NO 
 
Skip Q 19 and 20 if 1-18 response is no or don't know (silent code).  
If yes to any of the above ask Q19, Q20, & Q21 
19. Did any of these experiences you've just told me about (interviewer repeats IPV 
exposure reported). happen in the past year, that is since <insert date one year ago>? 
__ YES 
__ NO 
Silent code for Don't know/unsure 
20.  Please think back to the year before we first interviewed you at <insert clinic where 
she was interviewed> that would be starting on < insert date one year before ACASI> and 
ending on <insert date of ACASI>?  Did any of these experiences with an intimate 




Silent code for Don't know/unsure 
 
 21. Have you talked to anyone about these experiences? 
___ NO  Would you like to talk to someone? 
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 __If yes  at the end of our interview I will give you a number you can call. 
__If no  just in case you change your mind, at the end of our interview, I  
              will give you a number you can call. 
 ___ YES  Had you already talked to somebody before you joined this study? 
   ___ YES 
   ___ NO 
 
F. Side effects 
 
Now we want you to think back to when you first got involved in this study. 
1. A year ago {DATE OF BASELINE} we asked you some questions on a computer 
survey. Do you remember this?  
__ YES 
__  NO  SKIP TO Q3.  
 
2. Because of being asked these questions, did you have any small or big 
problems, or no problems?   Interviewers remind answers are confidential. 
a. Big problems  What were the big problems?    
b. Small problems?  What were the smaller problems?   
c. Both big and small problems  What were the big problems?  Smaller 
problems?   
d. No problems at all 
 
(Instructions to interviewers for problems probe for free text to include- description of 
problems including who, what, when, etc) 
 
3.  Do you remember if you received a list of services from the computer that time? 
 ___ Yes  (continue with next question) 
 ___      No  (skip to next section) 
 
4.  Did you share this list of services with anyone?  
__ Yes  who? {interviewer probe relationship} 
    __ No 
5.  Did you use the list to contact one of the services? 
 ___ Yes  
 ___ No  
6. Did you have any small or big problems, or no problems as a result of getting 
this list? 
___a. Big problems  What were the big problems?    
___b. Small problems?  What were the smaller problems?   
___c. Both big and small problems  What were the big problems?  Smaller 
problems?   
___d. No problems at all 
7. Before joining this study last year, had you ever called or visited an agency that 
provides help to women who have been abused by their intimate partner? 
___ YES 
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Thank you.  
 
(If respondent reported current exposure to IPV) I promised to give you a number you 
can call to talk about your experiences with your partner. The number is 312-864-1095. 
You can also call 877-863-6338. 
 
(All other respondents) Just in case you or someone you know should ever need help with 










Pledge of Confidentiality and Privacy  
I have read and understood the policies on the security and privacy of the information 
collected for Women’s IPV Screening Study in Obstetrics and Gynecology Clinics. These 
policies are detailed in the electronically stored IRB approved Study Protocol. 
I understand that all data and information to which I may have access is confidential and 
private and is not to be communicated to anyone in any manner, except as outlined in the 
policies.  
I have been made aware of the possible consequences of any intentional or unintentional 
breach of the Security and Privacy Policy.  
 
Printed Name___________________________________ 
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